PreveCeutical Welcomes Stephen Glover as Corporate Advisor
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
Brain
Quantum Sensors Market to Hit USD 839 Million by 2031 | Key Growth in Defense, Healthcare & IT – Valuates Reports
BANGALORE, India, May 23, 2025 /PRNewswire/ -- Quantum Sensors Market is Segmented by Type (Atomic Clock, Gravity Sensor, Magnetic Sensor,...
O’Shaughnessy Ventures Backs AI-Powered Dream Reconstruction
Ninon Lizé Masclef awarded $100,000 fellowship to turn brain-wave data into 3D visualizations of dreams GREENWICH, Conn., May 23, 2025 /PRNewswire/...
PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...
Neurostimulation Devices Market to Reach USD 17.2 Billion by 2031 – Driven by Demand for Pain and Parkinson’s Therapies | Valuates Reports
BANGALORE, India, May 22, 2025 /PRNewswire/ -- Neurostimulation Devices Market is Segmented by Type (Spinal Cord Stimulation (SCS), Gastric Electric...
Corundum Neuroscience and Corundum Systems Biology to Host Panel Sessions at First Ever SXSW London
Discussions to Focus on the Role of Sleep Innovation for Brain Health and the Influence of the Microbiome on Human...
Neurophet Participates ASNR 2025: Showcasing Clinical Utility of ‘Neurophet AQUA AD’
Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, including Neurophet AQUA ADCompany accelerates...
Neurogen Biomarking Announces Partnership with Aranscia
Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen's Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and...
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland, May...
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
Study is expected to deliver final device data and documentation needed for planned FDA IND submissionSARASOTA, FL, May 21, 2025...
ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease
Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa...
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery...
Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease
Maintains Brain Connectivity: GAL-201 prevents amyloid-beta (Aβ)–induced synaptic damage by maintaining long-term potentiation, a correlate for learning and memory.Improves Memory...
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team...
Rapport Therapeutics to Host 2025 Investor and Analyst Day
BOSTON and SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated...
Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of...
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the...
Brainomix Appoints Khush F. Mehta as Chair to Support Global Expansion and Commercial Growth
OXFORD, England and CHICAGO, May 21, 2025 /PRNewswire/ -- Brainomix, a global leader in AI-powered imaging solutions in stroke and lung...
The 10,000 Brains Project Launches the “Path-ND” Digital Brain Banking Program to Transform Neurodegenerative Disease Research
Funding from the Kissick Family Foundation Expands Frontotemporal Dementia Data; New Partnership with The Michael J. Fox Foundation Enhances Parkinson's Research OAKLAND, Calif., May 20, 2025 /PRNewswire/ -- The...
Expanding Dyslexia Training When Teachers Need It Most
ATLANTA, May 20, 2025 /PRNewswire/ -- The Rollins Center for Language & Literacy is partnering with the University of California and...